{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T02:47:10Z","timestamp":1791082030168,"version":"4.1.0"},"reference-count":67,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2004,2,24]],"date-time":"2004-02-24T00:00:00Z","timestamp":1077580800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2004,2,24]],"date-time":"2004-02-24T00:00:00Z","timestamp":1077580800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Breast Cancer Res"],"DOI":"10.1186\/bcr773","type":"journal-article","created":{"date-parts":[[2004,2,28]],"date-time":"2004-02-28T07:21:34Z","timestamp":1077952894000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":124,"title":["Red clover-derived isoflavones and mammographic breast density: a double-blind, randomized, placebo-controlled trial [ISRCTN42940165]"],"prefix":"10.1186","volume":"6","author":[{"given":"Charlotte","family":"Atkinson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruth ML","family":"Warren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evis","family":"Sala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mitch","family":"Dowsett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alison M","family":"Dunning","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine S","family":"Healey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shirley","family":"Runswick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas E","family":"Day","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheila A","family":"Bingham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2004,2,24]]},"reference":[{"key":"775_CR1","doi-asserted-by":"publisher","first-page":"95","DOI":"10.3109\/07853899709113696","volume":"29","author":"H Adlercreutz","year":"1997","unstructured":"Adlercreutz H, Mazur W: Phyto-oestrogens and Western diseases. Ann Med. 1997, 29: 95-120.","journal-title":"Ann Med"},{"key":"775_CR2","first-page":"1333S","volume":"Suppl","author":"KD Setchell","year":"1998","unstructured":"Setchell KD: Phytoestrogens: the biochemistry, physiology, and implications for human health of soy isoflavones. Am J Clin Nutr. 1998, Suppl: 1333S-1346S.","journal-title":"Am J Clin Nutr"},{"key":"775_CR3","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1080\/01635589609514470","volume":"26","author":"K Reinli","year":"1996","unstructured":"Reinli K, Block G: Phytoestrogen content of foods: a compendium of literature values. Nutr Cancer. 1996, 26: 123-148.","journal-title":"Nutr Cancer"},{"key":"775_CR4","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1080\/01635589909514752","volume":"33","author":"Z Chen","year":"1999","unstructured":"Chen Z, Zheng W, Custer LJ, Dai Q, Shu XO, Jin F, Franke AA: Usual dietary consumption of soy foods and its correlation with the excretion rate of isoflavonoids in overnight urine samples among Chinese women in Shanghai. Nutr Cancer. 1999, 33: 82-87.","journal-title":"Nutr Cancer"},{"key":"775_CR5","doi-asserted-by":"crossref","first-page":"1826","DOI":"10.1093\/jn\/131.6.1826","volume":"131","author":"MJ de Kleijn","year":"2001","unstructured":"de Kleijn MJ, van der Schouw YT, Wilson PW, Adlercreutz H, Mazur W, Grobbee DE, Jacques PF: Intake of dietary phytoestrogens is low in postmenopausal women in the United States: the Framingham study(1\u20134). J Nutr. 2001, 131: 1826-1832.","journal-title":"J Nutr"},{"key":"775_CR6","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1002\/ijc.2910540413","volume":"54","author":"DM Parkin","year":"1993","unstructured":"Parkin DM, Pisani P, Ferlay J: Estimates of the worldwide incidence of eighteen major cancers in 1985. Int J Cancer. 1993, 54: 594-606.","journal-title":"Int J Cancer"},{"key":"775_CR7","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1093\/oxfordjournals.aje.a009024","volume":"144","author":"X Ling","year":"1996","unstructured":"Ling X, Lu A, Zhao X, Chen X, Cummings SR: Very low rates of hip fracture in Beijing, People's Republic of China the Beijing Osteoporosis Project. Am J Epidemiol. 1996, 144: 901-907.","journal-title":"Am J Epidemiol"},{"key":"775_CR8","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1161\/01.CIR.90.1.583","volume":"90","author":"H Tunstall-Pedoe","year":"1994","unstructured":"Tunstall-Pedoe H, Kuulasmaa K, Amouyel P, Arveiler D, Rajakangas AM, Pajak A: Myocardial infarction and coronary deaths in the World Health Organization MONICA Project. Registration procedures, event rates, and case-fatality rates in 38 populations from 21 countries in four continents. Circulation. 1994, 90: 583-612.","journal-title":"Circulation"},{"key":"775_CR9","first-page":"785","volume":"5","author":"NL Petrakis","year":"1996","unstructured":"Petrakis NL, Barnes S, King EB, Lowenstein J, Wiencke J, Lee MM, Miike R, Kirk M, Coward L: Stimulatory influence of soy protein isolate on breast secretion in pre- and postmenopausal women. Cancer Epidemiol Biomarkers Prev. 1996, 5: 785-794.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"775_CR10","first-page":"4017","volume":"84","author":"DF Hargreaves","year":"1999","unstructured":"Hargreaves DF, Potten CS, Harding C, Shaw LE, Morton MS, Roberts SA, Howell A, Bundred NJ: Two-week dietary soy supplementation has an estrogenic effect on normal premenopausal breast. J Clin Endocrinol Metab. 1999, 84: 4017-4024. 10.1210\/jc.84.11.4017.","journal-title":"J Clin Endocrinol Metab"},{"key":"775_CR11","first-page":"1133","volume":"7","author":"NF Boyd","year":"1998","unstructured":"Boyd NF, Lockwood GA, Byng JW, Tritchler DL, Yaffe MJ: Mammographic densities and breast cancer risk. Cancer Epidemiol Biomarkers Prev. 1998, 7: 1133-1144.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"775_CR12","first-page":"163","volume":"154","author":"NF Boyd","year":"2001","unstructured":"Boyd NF, Lockwood GA, Martin LJ, Byng JW, Yaffe MJ, Tritchler DL: Mammographic density as a marker of susceptibility to breast cancer: a hypothesis. IARC Sci Publ. 2001, 154: 163-169.","journal-title":"IARC Sci Publ"},{"key":"775_CR13","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1148\/radiology.196.2.7617857","volume":"196","author":"MB Laya","year":"1995","unstructured":"Laya MB, Gallagher JC, Schreiman JS, Larson EB, Watson P, Weinstein L: Effect of postmenopausal hormonal replacement therapy on mammographic density and parenchymal pattern. Radiology. 1995, 196: 433-437.","journal-title":"Radiology"},{"key":"775_CR14","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1016\/S0039-6060(97)90072-6","volume":"122","author":"W Leung","year":"1997","unstructured":"Leung W, Goldberg F, Zee B, Sterns E: Mammographic density in women on postmenopausal hormone replacement therapy. Surgery. 1997, 122: 669-673. discussion 673-664","journal-title":"Surgery"},{"key":"775_CR15","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1148\/radiology.174.2.2136958","volume":"174","author":"PC Stomper","year":"1990","unstructured":"Stomper PC, Van Voorhis BJ, Ravnikar VA, Meyer JE: Mammographic changes associated with postmenopausal hormone replacement therapy: a longitudinal study. Radiology. 1990, 174: 487-490.","journal-title":"Radiology"},{"key":"775_CR16","doi-asserted-by":"publisher","first-page":"262","DOI":"10.7326\/0003-4819-130-4_Part_1-199902160-00003","volume":"130","author":"GA Greendale","year":"1999","unstructured":"Greendale GA, Reboussin BA, Sie A, Singh HR, Olson LK, Gatewood O, Bassett LW, Wasilauskas C, Bush T, Barrett-Connor E: Effects of estrogen and estrogen-progestin on mammographic parenchymal density. Postmenopausal Estrogen\/ Progestin Interventions (PEPI) Investigators. Ann Intern Med. 1999, 130: 262-269.","journal-title":"Ann Intern Med"},{"key":"775_CR17","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1016\/S0002-9378(99)70560-0","volume":"181","author":"E Lundstrom","year":"1999","unstructured":"Lundstrom E, Wilczek B, von Palffy Z, Soderqvist G, von Schoultz B: Mammographic breast density during hormone replacement therapy: differences according to treatment. Am J Obstet Gynecol. 1999, 181: 348-352.","journal-title":"Am J Obstet Gynecol"},{"key":"775_CR18","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1001\/jama.285.2.171","volume":"285","author":"CM Rutter","year":"2001","unstructured":"Rutter CM, Mandelson MT, Laya MB, Seger DJ, Taplin S: Changes in breast density associated with initiation, discontinuation, and continuing use of hormone replacement therapy. JAMA. 2001, 285: 171-176. 10.1001\/jama.285.2.171.","journal-title":"JAMA"},{"key":"775_CR19","first-page":"863","volume":"8","author":"C Atkinson","year":"1999","unstructured":"Atkinson C, Warren R, Bingham SA, Day NE: Mammographic patterns as a predictive biomarker of breast cancer risk: effect of tamoxifen. Cancer Epidemiol Biomarkers Prev. 1999, 8: 863-866.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"775_CR20","first-page":"911","volume":"9","author":"J Brisson","year":"2000","unstructured":"Brisson J, Brisson B, Cote G, Maunsell E, Berube S, Robert J: Tamoxifen and mammographic breast densities. Cancer Epidemiol Biomarkers Prev. 2000, 9: 911-915.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"775_CR21","first-page":"917","volume":"9","author":"CK Chow","year":"2000","unstructured":"Chow CK, Venzon D, Jones EC, Premkumar A, O'Shaughnessy J, Zujewski J: Effect of tamoxifen on mammographic density. Cancer Epidemiol Biomarkers Prev. 2000, 9: 917-921.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"775_CR22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/bcr410","volume":"4","author":"C Atkinson","year":"2002","unstructured":"Atkinson C, Bingham SA: Mammographic breast density as a biomarker of effects of isoflavones on the female breast. Br Cancer Res. 2002, 4: 1-4. 10.1186\/bcr410.","journal-title":"Br Cancer Res"},{"key":"775_CR23","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1093\/jnci\/89.7.488","volume":"89","author":"NF Boyd","year":"1997","unstructured":"Boyd NF, Greenberg C, Lockwood G, Little L, Martin L, Byng J, Yaffe M, Tritchler D: Effects at two years of a low-fat, high-carbohydrate diet on radiologic features of the breast: results from a randomized trial. Canadian Diet and Breast Cancer Prevention Study Group. J Natl Cancer Inst. 1997, 89: 488-496. 10.1093\/jnci\/89.7.488.","journal-title":"J Natl Cancer Inst"},{"key":"775_CR24","first-page":"151","volume":"9","author":"CM Vachon","year":"2000","unstructured":"Vachon CM, Kushi LH, Cerhan JR, Kuni CC, Sellers TA: Association of diet and mammographic breast density in the Minnesota breast cancer family cohort. Cancer Epidemiol Biomarkers Prev. 2000, 9: 151-160.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"775_CR25","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1054\/bjoc.2000.1151","volume":"83","author":"E Sala","year":"2000","unstructured":"Sala E, Warren R, Duffy S, Welch A, Luben R, Day N: High risk mammographic parenchymal patterns and diet: a case-control study. Br J Cancer. 2000, 83: 121-126. 10.1054\/bjoc.2000.1151.","journal-title":"Br J Cancer"},{"key":"775_CR26","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1186\/bcr285","volume":"3","author":"G Maskarinec","year":"2001","unstructured":"Maskarinec G, Meng L: An investigation of soy intake and mammographic characteristics in Hawaii. Br Can Res. 2001, 3: 134-141. 10.1186\/bcr285.","journal-title":"Br Can Res"},{"key":"775_CR27","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1097\/00008469-200304000-00011","volume":"12","author":"G Maskarinec","year":"2003","unstructured":"Maskarinec G, Williams AE, Carlin L: Mammographic densities in a one-year isoflavone intervention. Eur J Cancer Prev. 2003, 12: 165-169. 10.1097\/00008469-200304000-00011.","journal-title":"Eur J Cancer Prev"},{"key":"775_CR28","doi-asserted-by":"publisher","first-page":"1130","DOI":"10.2214\/ajr.126.6.1130","volume":"126","author":"JN Wolfe","year":"1976","unstructured":"Wolfe JN: Breast patterns as an index of risk for developing breast cancer. AJR Am J Roentgenol. 1976, 126: 1130-1137.","journal-title":"AJR Am J Roentgenol"},{"key":"775_CR29","doi-asserted-by":"crossref","first-page":"1362S","DOI":"10.1093\/jn\/131.4.1362S","volume":"Suppl","author":"KD Setchell","year":"2001","unstructured":"Setchell KD, Brown NM, Desai P, Zimmer-Nechemias L, Wolfe BE, Brashear WT, Kirschner AS, Cassidy A, Heubi JE: Bioavailability of pure isoflavones in healthy humans and analysis of commercial soy isoflavone supplements. J Nutr. 2001, Suppl: 1362S-1375S.","journal-title":"J Nutr"},{"key":"775_CR30","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1136\/jms.5.4.207","volume":"5","author":"E Sala","year":"1998","unstructured":"Sala E, Warren R, McCann J, Duffy S, Day N, Luben R: Mammographic parenchymal patterns and mode of detection: implications for the breast screening programme. J Med Screen. 1998, 5: 207-212.","journal-title":"J Med Screen"},{"key":"775_CR31","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1016\/0022-3999(76)90005-2","volume":"20","author":"JG Greene","year":"1976","unstructured":"Greene JG: A factor analytic study of climacteric symptoms. J Psychosom Res. 1976, 20: 425-430. 10.1016\/0022-3999(76)90005-2.","journal-title":"J Psychosom Res"},{"key":"775_CR32","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1042\/cs0640629","volume":"64","author":"S Bingham","year":"1983","unstructured":"Bingham S, Cummings JH: The use of 4-aminobenzoic acid as a marker to validate the completeness of 24 h urine collections in man. Clin Sci. 1983, 64: 629-635.","journal-title":"Clin Sci"},{"key":"775_CR33","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1017\/S1368980099000786","volume":"2","author":"G Johansson","year":"1999","unstructured":"Johansson G, Bingham S, Vahter M: A method to compensate for incomplete 24-hour urine collections in nutritional epidemiology studies. Pub Health Nutr. 1999, 2: 587-591.","journal-title":"Pub Health Nutr"},{"key":"775_CR34","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1016\/S0021-9673(01)94608-4","volume":"386","author":"KD Setchell","year":"1987","unstructured":"Setchell KD, Welsh MB, Lim CK: High-performance liquid chromatographic analysis of phytoestrogens in soy protein preparations with ultraviolet, electrochemical and thermospray mass spectrometric detection. J Chromatogr. 1987, 386: 315-323. 10.1016\/S0021-9673(01)94608-4.","journal-title":"J Chromatogr"},{"key":"775_CR35","doi-asserted-by":"publisher","first-page":"18","DOI":"10.3181\/00379727-208-43826","volume":"208","author":"AA Franke","year":"1995","unstructured":"Franke AA, Custer LJ, Cerna CM, Narala K: Rapid HPLC analysis of dietary phytoestrogens from legumes and from human urine. Proc Soc Exp Biol Med. 1995, 208: 18-26.","journal-title":"Proc Soc Exp Biol Med"},{"key":"775_CR36","doi-asserted-by":"publisher","first-page":"2045","DOI":"10.1038\/bjc.1998.340","volume":"77","author":"AM Dunning","year":"1998","unstructured":"Dunning AM, Healey CS, Pharoah PD, Foster NA, Lipscombe JM, Redman KL, Easton DF, Day NE, Ponder BA: No association between a polymorphism in the steroid metabolism gene CYP17 and risk of breast cancer. Br J Cancer. 1998, 77: 2045-2047.","journal-title":"Br J Cancer"},{"key":"775_CR37","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1093\/carcin\/21.2.189","volume":"21","author":"CS Healey","year":"2000","unstructured":"Healey CS, Dunning AM, Durocher F, Teare D, Pharoah PD, Luben RN, Easton DF, Ponder BA: Polymorphisms in the human aromatase cytochrome P450 gene (CYP19) and breast cancer risk. Carcinogenesis. 2000, 21: 189-193. 10.1093\/carcin\/21.2.189.","journal-title":"Carcinogenesis"},{"key":"775_CR38","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1038\/ng0495-341","volume":"9","author":"KJ Livak","year":"1995","unstructured":"Livak KJ, Marmaro J, Todd JA: Towards fully automated genome-wide polymorphism screening. Nat Genet. 1995, 9: 341-342.","journal-title":"Nat Genet"},{"key":"775_CR39","first-page":"1957","volume":"47","author":"M Dowsett","year":"1987","unstructured":"Dowsett M, Goss PE, Powles TJ, Hutchinson G, Brodie AM, Jeffcoate SL, Coombes RC: Use of the aromatase inhibitor 4-hydroxyandrostenedione in postmenopausal breast cancer: optimization of therapeutic dose and route. Cancer Res. 1987, 47: 1957-1961.","journal-title":"Cancer Res"},{"key":"775_CR40","first-page":"659","volume":"2","author":"DR Ferry","year":"1996","unstructured":"Ferry DR, Smith A, Malkhandi J, Fyfe DW, deTakats PG, Anderson D, Baker J, Kerr DJ: Phase I clinical trial of the flavonoid quercetin: pharmacokinetics and evidence for in vivo tyrosine kinase inhibition. Clin Cancer Res. 1996, 2: 659-668.","journal-title":"Clin Cancer Res"},{"key":"775_CR41","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.1136\/bmj.311.7013.1145","volume":"311","author":"MJ Campbell","year":"1995","unstructured":"Campbell MJ, Julious SA, Altman DG: Estimating sample sizes for binary, ordered categorical, and continuous outcomes in two group comparisons. BMJ. 1995, 311: 1145-1148. (Published erratum appears in BMJ 1996, 312:96.)","journal-title":"BMJ"},{"key":"775_CR42","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1016\/S0140-6736(03)14596-5","volume":"362","author":"V Beral","year":"2003","unstructured":"Beral V: Breast cancer and hormone-replacement therapy in the Million Women Study. Lancet. 2003, 362: 419-427. 10.1016\/S0140-6736(03)14065-2.","journal-title":"Lancet"},{"key":"775_CR43","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1001\/jama.288.3.321","volume":"288","author":"JE Rossouw","year":"2002","unstructured":"Rossouw JE, Anderson GL, Prentice RL, LaCroix AZ, Kooperberg C, Stefanick ML, Jackson RD, Beresford SA, Howard BV, Johnson KC, Kotchen JM, Ockene J: Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial. JAMA. 2002, 288: 321-333.","journal-title":"JAMA"},{"key":"775_CR44","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1067\/mob.2002.121896","volume":"186","author":"E Lundstrom","year":"2002","unstructured":"Lundstrom E, Christow A, Kersemaekers W, Svane G, Azavedo E, Soderqvist G, Mol-Arts M, Barkfeldt J, von Schoultz B: Effects of tibolone and continuous combined hormone replacement therapy on mammographic breast density. Am J Obstet Gynecol. 2002, 186: 717-722. 10.1067\/mob.2002.121896.","journal-title":"Am J Obstet Gynecol"},{"key":"775_CR45","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1046\/j.1523-5408.2002.05602.x","volume":"5","author":"MJ Messina","year":"2002","unstructured":"Messina MJ: Soy foods and soybean isoflavones and menopausal health. Nutr Clin Care. 2002, 5: 272-282. 10.1046\/j.1523-5408.2002.05602.x.","journal-title":"Nutr Clin Care"},{"key":"775_CR46","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1016\/S1068-607X(00)00055-X","volume":"7","author":"D Carusi","year":"2000","unstructured":"Carusi D: Phytoestrogens as hormone replacement therapy: an evidence-based approach. Prim Care Update Ob Gyns. 2000, 7: 253-259. 10.1016\/S1068-607X(00)00055-X.","journal-title":"Prim Care Update Ob Gyns"},{"key":"775_CR47","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1093\/jnci\/93.1.51","volume":"93","author":"M Freedman","year":"2001","unstructured":"Freedman M, San Martin J, O'Gorman J, Eckert S, Lippman ME, Lo SC, Walls EL, Zeng J: Digitized mammography: a clinical trial of postmenopausal women randomly assigned to receive raloxifene, estrogen, or placebo. J Natl Cancer Inst. 2001, 93: 51-56. 10.1093\/jnci\/93.1.51.","journal-title":"J Natl Cancer Inst"},{"key":"775_CR48","doi-asserted-by":"publisher","first-page":"1830","DOI":"10.1093\/jnci\/90.23.1830","volume":"90","author":"C Nagata","year":"1998","unstructured":"Nagata C, Takatsuka N, Inaba S, Kawakami N, Shimizu H: Effect of soymilk consumption on serum estrogen concentrations in premenopausal Japanese women. J Natl Cancer Inst. 1998, 90: 1830-1835. 10.1093\/jnci\/90.23.1830.","journal-title":"J Natl Cancer Inst"},{"key":"775_CR49","first-page":"4112","volume":"60","author":"L-JW Lu","year":"2000","unstructured":"Lu L-JW, Anderson KE, Grady JJ, Kohen F, Nagamani M: Decreased ovarian hormones during a soya diet: implications for breast cancer prevention. Cancer Res. 2000, 60: 4112-4121.","journal-title":"Cancer Res"},{"key":"775_CR50","first-page":"63","volume":"5","author":"LJ Lu","year":"1996","unstructured":"Lu LJ, Anderson KE, Grady JJ, Nagamani M: Effects of soya consumption for one month on steroid hormones in premenopausal women: implications for breast cancer risk reduction. Cancer Epidemiol Biomarkers Prev. 1996, 5: 63-70.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"775_CR51","first-page":"3479","volume":"84","author":"AM Duncan","year":"1999","unstructured":"Duncan AM, Underhill KE, Xu X, Lavalleur J, Phipps WR, Kurzer MS: Modest hormonal effects of soy isoflavones in postmenopausal women. J Clin Endocrinol Metab. 1999, 84: 3479-3484. 10.1210\/jc.84.10.3479.","journal-title":"J Clin Endocrinol Metab"},{"key":"775_CR52","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1093\/ajcn\/60.3.333","volume":"60","author":"A Cassidy","year":"1994","unstructured":"Cassidy A, Bingham S, Setchell KD: Biological effects of a diet of soy protein rich in isoflavones on the menstrual cycle of premenopausal women. Am J Clin Nutr. 1994, 60: 333-340.","journal-title":"Am J Clin Nutr"},{"key":"775_CR53","first-page":"192","volume":"84","author":"AM Duncan","year":"1999","unstructured":"Duncan AM, Merz BE, Xu X, Nagel TC, Phipps WR, Kurzer MS: Soy isoflavones exert modest hormonal effects in premenopausal women. J Clin Endocrinol Metab. 1999, 84: 192-197. 10.1210\/jc.84.1.192.","journal-title":"J Clin Endocrinol Metab"},{"key":"775_CR54","first-page":"3045","volume":"86","author":"LJ Lu","year":"2001","unstructured":"Lu LJ, Anderson KE, Grady JJ, Nagamani M: Effects of an isoflavone-free soy diet on ovarian hormones in premenopausal women. J Clin Endocrinol Metab. 2001, 86: 3045-3052. 10.1210\/jc.86.7.3045.","journal-title":"J Clin Endocrinol Metab"},{"key":"775_CR55","first-page":"1685","volume":"80","author":"DD Baird","year":"1995","unstructured":"Baird DD, Umbach DM, Lansdell L, Hughes CL, Setchell KD, Weinberg CR, Haney AF, Wilcox AJ, McLachlan JA: Dietary intervention study to assess estrogenicity of dietary soy among postmenopausal women. J Clin Endocrinol Metab. 1995, 80: 1685-1690. 10.1210\/jc.80.5.1685.","journal-title":"J Clin Endocrinol Metab"},{"key":"775_CR56","doi-asserted-by":"crossref","first-page":"5592","DOI":"10.1016\/S0021-9258(18)45614-1","volume":"262","author":"T Akiyama","year":"1987","unstructured":"Akiyama T, Ishida J, Nakagawa S, Ogawara H, Watanabe S, Itoh N, Shibuya M, Fukami Y: Genistein, a specific inhibitor of tyrosine-specific protein kinases. J Biol Chem. 1987, 262: 5592-5595.","journal-title":"J Biol Chem"},{"key":"775_CR57","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/0378-5122(95)00899-V","volume":"21","author":"AL Murkies","year":"1995","unstructured":"Murkies AL, Lombard C, Strauss BJ, Wilcox G, Burger HG, Morton MS: Dietary flour supplementation decreases postmenopausal hot flushes: effect of soy and wheat. Maturitas. 1995, 21: 189-195. 10.1016\/0378-5122(95)00899-V.","journal-title":"Maturitas"},{"key":"775_CR58","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1097\/00042192-199704020-00005","volume":"4","author":"A Brzezinski","year":"1997","unstructured":"Brzezinski A, Adlercreutz H, Shaoul R, R\u00f6sler A, Shmueli A, Tanos V, Schenker JG: Short-term effects of phytoestrogen-rich diet on postmenopausal women. Menopause. 1997, 4: 89-94.","journal-title":"Menopause"},{"key":"775_CR59","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1016\/S0029-7844(97)00597-8","volume":"91","author":"P Albertazzi","year":"1998","unstructured":"Albertazzi P, Pansini F, Bonaccorsi G, Zanotti L, Forini E, De Aloysio D: The effect of dietary soy supplementation on hot flushes. Obstet Gynecol. 1998, 91: 6-11. 10.1016\/S0029-7844(97)00597-8.","journal-title":"Obstet Gynecol"},{"key":"775_CR60","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1097\/00042192-200101000-00005","volume":"8","author":"A St Germain","year":"2001","unstructured":"St Germain A, Peterson CT, Robinson JG, Alekel DL: Isoflavone-rich or isoflavone-poor soy protein does not reduce menopausal symptoms during 24 weeks of treatment. Menopause. 2001, 8: 17-26. 10.1097\/00042192-200101000-00005.","journal-title":"Menopause"},{"key":"775_CR61","doi-asserted-by":"publisher","first-page":"79","DOI":"10.3109\/13697139909025570","volume":"2","author":"DC Knight","year":"1999","unstructured":"Knight DC, Howes JB, Eden JA: The effect of Promensil, an isoflavone extract, on menopausal symptoms. Climacteric. 1999, 2: 79-84.","journal-title":"Climacteric"},{"key":"775_CR62","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1080\/cmt.4.1.13.18","volume":"4","author":"DC Knight","year":"2001","unstructured":"Knight DC, Howes JB, Eden JA, Howes LG: Effects on menopausal symptoms and acceptability of isoflavone-containing soy powder dietary supplementation. Climacteric. 2001, 4: 13-18.","journal-title":"Climacteric"},{"key":"775_CR63","doi-asserted-by":"publisher","first-page":"85","DOI":"10.3109\/13697139909025571","volume":"2","author":"RJ Baber","year":"1999","unstructured":"Baber RJ, Templeman C, Morton T, Kelly GE, West L: Randomized placebo-controlled trial of an isoflavone supplement and menopausal symptoms in women. Climacteric. 1999, 2: 85-92.","journal-title":"Climacteric"},{"key":"775_CR64","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/S0378-5122(02)00080-4","volume":"42","author":"PHM Van de Weijer","year":"2002","unstructured":"Van de Weijer PHM, Barentsen R: Isoflavones from red clover (Promensil) significantly reduce menopausal hot flush symptoms compared with placebo. Maturitas. 2002, 42: 187-193. 10.1016\/S0378-5122(02)00080-4.","journal-title":"Maturitas"},{"key":"775_CR65","first-page":"843","volume":"8","author":"AM Dunning","year":"1999","unstructured":"Dunning AM, Healey CS, Pharoah PD, Teare MD, Ponder BA, Easton DF: A systematic review of genetic polymorphisms and breast cancer risk. Cancer Epidemiol Biomarkers Prev. 1999, 8: 843-854.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"775_CR66","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1093\/mutage\/17.2.119","volume":"17","author":"Z Ye","year":"2002","unstructured":"Ye Z, Parry JM: The CYP17 MspA1 polymorphism and breast cancer risk: a meta-analysis. Mutagenesis. 2002, 17: 119-126. 10.1093\/mutage\/17.2.119.","journal-title":"Mutagenesis"},{"key":"775_CR67","doi-asserted-by":"publisher","first-page":"1319","DOI":"10.1046\/j.1471-0528.2002.02214.x","volume":"109","author":"Million Women Study Collaborators","year":"2002","unstructured":"Million Women Study Collaborators: Patterns of use of hormone replacement therapy in one million women in Britain, 1996\u20132000. Br J Obstet Gynaecol. 2002, 109: 1319-1330.","journal-title":"Br J Obstet Gynaecol"}],"container-title":["Breast Cancer Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/bcr773.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/bcr773\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/bcr773.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,25]],"date-time":"2024-04-25T16:32:16Z","timestamp":1714062736000},"score":1,"resource":{"primary":{"URL":"https:\/\/breast-cancer-research.biomedcentral.com\/articles\/10.1186\/bcr773"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,2,24]]},"references-count":67,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2004,6]]}},"alternative-id":["775"],"URL":"https:\/\/doi.org\/10.1186\/bcr773","relation":{},"ISSN":["1465-542X"],"issn-type":[{"value":"1465-542X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2004,2,24]]},"assertion":[{"value":"9 September 2003","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 December 2003","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 February 2004","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 February 2004","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}],"article-number":"R170"}}